# Relevance of [68Ga]Ga -PentixaFor-PET for Initial Staging and Therapeutic Evaluation of Multiple Myeloma

> **NCT04561492** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Nantes University Hospital** · enrollment: 45 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** [68Ga]Ga-PentixaFor

## Key facts

- **NCT ID:** NCT04561492
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-09-21
- **Primary completion:** 2029-12-21
- **Final completion:** 2030-05-21
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04561492

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04561492, "Relevance of [68Ga]Ga -PentixaFor-PET for Initial Staging and Therapeutic Evaluation of Multiple Myeloma". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT04561492. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*